Xing Li
18Patents
3h-index
21Co-inventors
60Inventor score
Filing activity: Jun 4, 2003 → Jun 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9051375B2 | Alkali-resistant variants of protein A and their use in affinity chromatography | Chemistry; Metallurgy | 20 | Active |
| US9040661B2 | Support for affinity chromatography and method for isolating immunoglobulin | Chemistry; Metallurgy | 18 | Active |
| US7101559B2 | Immunomodulatory protein and useful embodiments thereof | Chemistry; Metallurgy | 6 | Expired |
| US7893272B2 | Reagents and kits for detection of influenza virus and the like | Physics | 3 | Active |
| US7718368B2 | Immunomodulatory protein and useful embodiments thereof | Chemistry; Metallurgy | 1 | Active |
| US11885952B2 | Optics, device, and system for assaying and imaging | Physics | 1 | Active |
| US11593590B2 | Efficient training and accuracy improvement of imaging based assay | Physics | 1 | Active |
| US8558004B2 | Reagents and kits for detection of influenza virus and the like | Physics | 1 | Active |
| US12007320B2 | Assay detection, accuracy and reliability improvement | Physics | 1 | Active |
| US11346764B2 | Image-based assay using intelligent monitoring structures | Physics | 1 | Active |
| US11674883B2 | Image-based assay performance improvement | Physics | 0 | Active |
| US12248533B2 | Efficient training and accuracy improvement of imaging based assay | Physics | 0 | Active |
| US11709163B2 | Methods for simultaneous determination of serological profile and estimation of duration post HIV infection | Physics | 0 | Active |
| US12383587B2 | AAV triple-plasmid system | Chemistry; Metallurgy | 0 | Active |
| US11719618B2 | Assay accuracy improvement | Physics | 0 | Active |
| US11733151B2 | Assay detection, accuracy and reliability improvement | Physics | 0 | Active |
| US8227569B2 | Immunomodulatory protein and useful embodiments thereof | Chemistry; Metallurgy | 0 | Active |
| US11981912B2 | Adeno associated virus vectors for the treatment of hunter disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.